Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Annalisa Schirizzi
Observed names:
A. Schirizzi,
Schirizzi, Annalisa
Institution:
Gastroenterology Hospital "Saverio de Bellis"
Observed institutions:
Casa Sollievo della Sofferenza,
Gastroenterology Hospital "Saverio de Bellis",
University of Bari Aldo Moro
ORCID:
0000-0001-6075-7791
Observed ORCID:
0000-0001-6075-7791
OpenAlex ID:
A5036855097
Autotaxin–Lysophosphatidate Axis: Promoter of Cancer Development and Possible Therapeutic Implications
2024
·
Carmelo Laface
, Angela Dalia Ricci
, et al.
·
International Journal of Molecular Sciences
·
26
Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications
2024
·
Angela Dalia Ricci
, Alessandro Rizzo
, et al.
·
Cancers
·
21
PDF
The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines
2023
·
Annalisa Schirizzi
, Marialessandra Contino
, et al.
·
Frontiers in Oncology
·
17
PDF
Exon-Trapping Assay Improves Clinical Interpretation of COL11A1 and COL11A2 Intronic Variants in Stickler Syndrome Type 2 and Otospondylomegaepiphyseal Dysplasia
2020
·
Lucia Micale
, Silvia Morlino
, et al.
·
Genes
·
16
PDF
Pharmacometric and Digital Twin modeling for adaptive scheduling of combination therapy in advanced gastric cancer
2025
·
Michela Prunella
, Nicola Altini
, et al.
·
Computer Methods and Programs in Biomedicine
·
15
Insights into the molecular pathogenesis of cardiospondylocarpofacial syndrome: MAP3K7 c.737-7A > G variant alters the TGFβ-mediated α-SMA cytoskeleton assembly and autophagy
2020
·
Lucia Micale
, Silvia Morlino
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
·
15
Targeting Angiogenesis in the Era of Biliary Tract Cancer Immunotherapy: Biological Rationale, Clinical Implications, and Future Research Avenues
2023
·
Annalisa Schirizzi
, Giampiero De Leonardis
, et al.
·
Cancers
·
12
PDF
VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment
2023
·
Annalisa Schirizzi
, Aram Arshadi
, et al.
·
Biomedicines
·
11
PDF
Circulating miR-23b-3p, miR-30e-3p, and miR-205-5p as Novel Predictive Biomarkers for Ramucirumab–Paclitaxel Therapy Outcomes in Advanced Gastric Cancer
2024
·
Emanuele Piccinno
, Annalisa Schirizzi
, et al.
·
International Journal of Molecular Sciences
·
9
PDF
Variations in Circulating Levels of Angiopoietin-2 Over Time Are Predictive of Ramucirumab–Paclitaxel Therapy Outcome in Advanced Gastric Cancer: Results of Prospective Study
2022
·
Rosalba D’Alessandro
, Maria Grazia Refolo
, et al.
·
Frontiers in Oncology
·
7
PDF
Unravelling Paclitaxel Resistance in Gastric Cancer: The Role of Small Extracellular Vesicles in Epithelial Mesenchymal Transition and Extracellular Matrix Remodelling
2025
·
Giorgia Panzetta
, Annalisa Schirizzi
, et al.
·
Cancers
·
6
Development of potent isoflavone-based formyl peptide receptor 1 (FPR1) antagonists and their effects in gastric cancer cell models
2023
·
Fabio Francavilla
, Federica Sarcina
, et al.
·
European Journal of Medicinal Chemistry
·
6
Durvalumab in Advanced Cholangiocarcinoma: Is Someone Knocking Down the Door?
2023
·
Angela Dalia Ricci
, Rosalba D'Alessandro
, et al.
·
Immunotherapy
·
6
Automated Pathomic Analysis of Angiogenesis and Immune Profiles Unveils an Interpretable Prognostic Biomarker in Colon and Gastric Cancers
2025
·
Michela Prunella
, Nicola Altini
, et al.
·
IEEE Journal of Biomedical and Health Informatics
·
3
Loss-of-function variants in exon 4 of TAB2 cause a recognizable multisystem disorder with cardiovascular, facial, cutaneous, and musculoskeletal involvement
2021
·
Lucia Micale
, Silvia Morlino
, et al.
·
Genetics in Medicine
·
3
PDF
CC48 a new CB2R agonist/FAAH inhibitor dual drug blocks gastric cancer progression and overcomes paclitaxel resistance
2025
·
Annalisa Schirizzi
, Natasha Renna
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
2
Corrigendum: Variations in circulating levels of angiopoietin-2 over time are predictive of ramucirumab–paclitaxel therapy outcome in advanced gastric cancer: results of prospective study
2023
·
Rosalba D’Alessandro
, Maria Grazia Refolo
, et al.
·
Frontiers in Oncology
·
2
PDF
Synthesis and biological evaluation of novel fused pyridopyrimidine derivatives as topoisomerase I inhibitors and as potential antitumor agents: promising results in lung, ovary and gastric cancer
2026
·
Leyre Lopez-Aguileta
, Endika Martín-Encinas
, et al.
·
European Journal of Medicinal Chemistry
·
1
High levels of autotaxin and lysophosphatidic acid predict poor outcome in treatment of resectable gastric carcinoma
2024
·
Annalisa Schirizzi
, Rossella Donghia
, et al.
·
European Journal of Cancer
·
1
PDF
P-379 ARID1A as a prognostic biomarker in gastroesophageal cancer: A genomic database analysis
2023
·
A. Ricci
, A. Schirizzi
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
27
Citation count:
179
H-index:
9
I10-index:
8
Year
Topic
Type